84 related articles for article (PubMed ID: 12628305)
1. A high-throughput cell-based reporter gene system for measurement of CYP1A1 induction.
Cui X; Palamanda J; Norton L; Thomas A; Lau YY; White RE; Cheng KC
J Pharmacol Toxicol Methods; 2002; 47(3):143-51. PubMed ID: 12628305
[TBL] [Abstract][Full Text] [Related]
2. Regulation of cytochrome P450 in cultured human colonic cells.
Rosenberg DW; Leff T
Arch Biochem Biophys; 1993 Jan; 300(1):186-92. PubMed ID: 8380963
[TBL] [Abstract][Full Text] [Related]
3. The presence of inducible cytochrome P450 types 1A1 and 1A2 in the BeWo cell line.
Avery ML; Meek CE; Audus KL
Placenta; 2003 Jan; 24(1):45-52. PubMed ID: 12495659
[TBL] [Abstract][Full Text] [Related]
4. Cytochrome P450 1A1 (CYP1A1) in blood lymphocytes evidence for catalytic activity and mRNA expression.
Dey A; Parmar D; Dayal M; Dhawan A; Seth PK
Life Sci; 2001 Jun; 69(4):383-93. PubMed ID: 11459429
[TBL] [Abstract][Full Text] [Related]
5. 3-Methylcholanthrene elicits DNA adduct formation in the CYP1A1 promoter region and attenuates reporter gene expression in rat H4IIE cells.
Moorthy B; Muthiah K; Fazili IS; Kondraganti SR; Wang L; Couroucli XI; Jiang W
Biochem Biophys Res Commun; 2007 Mar; 354(4):1071-7. PubMed ID: 17276403
[TBL] [Abstract][Full Text] [Related]
6. Differential in vivo effects of alpha-naphthoflavone and beta-naphthoflavone on CYP1A1 and CYP2E1 in rat liver, lung, heart, and kidney.
Sinal CJ; Webb CD; Bend JR
J Biochem Mol Toxicol; 1999; 13(1):29-40. PubMed ID: 9890445
[TBL] [Abstract][Full Text] [Related]
7. Pharmacologic profiling of human and rat cytochrome P450 1A1 and 1A2 induction and competition.
Westerink WM; Stevenson JC; Schoonen WG
Arch Toxicol; 2008 Dec; 82(12):909-21. PubMed ID: 18493746
[TBL] [Abstract][Full Text] [Related]
8. Distribution and induction of cytochrome P450 1A1 and 1A2 in rat brain.
Morse DC; Stein AP; Thomas PE; Lowndes HE
Toxicol Appl Pharmacol; 1998 Sep; 152(1):232-9. PubMed ID: 9772218
[TBL] [Abstract][Full Text] [Related]
9. Pretranslational induction of cytochrome P4501A enzymes by beta-naphthoflavone and 3-methylcholanthrene occurs in different liver zones.
Oinonen T; Saarikoski S; Husgafvel-Pursiainen K; Hirvonen A; Lindros KO
Biochem Pharmacol; 1994 Dec; 48(12):2189-97. PubMed ID: 7811300
[TBL] [Abstract][Full Text] [Related]
10. Differential induction of ethoxyresorufin-O-deethylase in tissues of the rat placenta.
Shiverick KT; Swanson C; Salhab AS; James MO
J Pharmacol Exp Ther; 1986 Sep; 238(3):1108-13. PubMed ID: 3746661
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the induction of a 4S beta-naphthoflavone-binding protein, cytochrome P450 1A1 and NAD(P)H:quinone oxidoreductase in beta-naphthoflavone-treated rats.
Brauze D
Toxicol Lett; 2004 Sep; 152(2):111-6. PubMed ID: 15302092
[TBL] [Abstract][Full Text] [Related]
12. In vitro metabolism and inductive or inhibitive effect of DL111 on rat cytochrome P4501A enzyme.
Hu YZ; Yao TW
Chem Biol Interact; 2004 Mar; 147(2):109-17. PubMed ID: 15013813
[TBL] [Abstract][Full Text] [Related]
13. Impact of beta-naphthoflavone on genotoxicity of food-derived carcinogens.
Hodek P; Krizkova J; Frei E; Singh R; Arlt VM; Stiborova M
Neuro Endocrinol Lett; 2011; 32 Suppl 1():25-34. PubMed ID: 22167217
[TBL] [Abstract][Full Text] [Related]
14. Induction of cytochrome P450 1A1 by ketoconazole and itraconazole but not fluconazole in murine and human hepatoma cell lines.
Korashy HM; Shayeganpour A; Brocks DR; El-Kadi AO
Toxicol Sci; 2007 May; 97(1):32-43. PubMed ID: 17283379
[TBL] [Abstract][Full Text] [Related]
15. N-methoxyindole-3-carbinol is a more efficient inducer of cytochrome P-450 1A1 in cultured cells than indol-3-carbinol.
Stephensen PU; Bonnesen C; Schaldach C; Andersen O; Bjeldanes LF; Vang O
Nutr Cancer; 2000; 36(1):112-21. PubMed ID: 10798223
[TBL] [Abstract][Full Text] [Related]
16. Cytochrome P450 1A1 (CYP1A1) inhibitor alpha-naphthoflavone interferes with UDP-glucuronosyltransferase (UGT) activity in intact but not in permeabilized hepatic microsomes from 3-methylcholanthrene-treated rats: possible involvement of UGT-P450 interactions.
Taura K; Naito E; Ishii Y; Mori MA; Oguri K; Yamada H
Biol Pharm Bull; 2004 Jan; 27(1):56-60. PubMed ID: 14709899
[TBL] [Abstract][Full Text] [Related]
17. Oltipraz inhibits 3-methylcholanthrene induction of CYP1A1 by CCAAT/enhancer-binding protein activation.
Cho IJ; Kim SG
J Biol Chem; 2003 Nov; 278(45):44103-12. PubMed ID: 12941938
[TBL] [Abstract][Full Text] [Related]
18. Induction of CYP1A1 by beta-naphthoflavone in IEC-18 rat intestinal epithelial cells and potentiation of induction by dibutyryl cAMP.
Zhang QY; He W; Dunbar D; Kaminsky L
Biochem Biophys Res Commun; 1997 Apr; 233(3):623-6. PubMed ID: 9168901
[TBL] [Abstract][Full Text] [Related]
19. Induction of CYP1A1 mRNA in rat epidermis and cultured human epidermal keratinocytes by benz(a)anthracene and beta-naphthoflavone.
Khan IU; Bickers DR; Haqqi TM; Mukhtar H
Drug Metab Dispos; 1992; 20(5):620-4. PubMed ID: 1358564
[TBL] [Abstract][Full Text] [Related]
20. Mechanism-based inactivation of cytochrome P450 1A1 by N-aralkyl-1-aminobenzotriazoles in guinea pig kidney in vivo and in vitro: minimal effects on metabolism of arachidonic acid by renal P450-dependent monooxygenases.
Knickle LC; Webb CD; House AA; Bend JR
J Pharmacol Exp Ther; 1993 Nov; 267(2):758-64. PubMed ID: 8246152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
